NASDAQ:BYSI BeyondSpring (BYSI) Stock Price, News & Analysis $0.48 +0.02 (+5.00%) As of 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC Filings About BeyondSpring Stock (NASDAQ:BYSI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BeyondSpring alerts:Sign Up Key Stats Today's Range$0.46▼$0.5250-Day Range$0.43▼$1.1252-Week Range$0.42▼$2.44Volume41,164 shsAverage Volume283,915 shsMarket Capitalization$19.00 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview BeyondSpring Inc. (NASDAQ: BYSI) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases. The company’s lead product candidate is plinabulin, a small-molecule agent designed to provide both anticancer and immune-modulating effects. Plinabulin has been investigated as a treatment to prevent chemotherapy-induced neutropenia, a potentially serious reduction in infection-fighting white blood cells that can occur during cancer treatment. BeyondSpring has also studied the candidate in combination with chemotherapy for patients with advanced or metastatic cancer, including non-small cell lung cancer. Founded in 2010, BeyondSpring has conducted clinical development activities in the United States, China and other international markets. The company was co-founded and is led by Lan Huang, Ph.D., who has served as its chief executive officer and chairman. As a clinical-stage company, BeyondSpring’s products remain subject to regulatory review and successful clinical development.AI Generated. May Contain Errors. Read More BeyondSpring Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreBYSI MarketRank™: 0.341378420235 of 5 starsBeyondSpring scored higher than 7% of companies evaluated by MarketBeat, and ranked 903rd out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingBeyondSpring has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageBeyondSpring has only been the subject of 1 research reports in the past 90 days.Read more about BeyondSpring's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of BeyondSpring is -3.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BeyondSpring is -3.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about BeyondSpring's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.10% of the float of BeyondSpring has been sold short.Short Interest Ratio / Days to CoverBeyondSpring has a short interest ratio ("days to cover") of 35.77, which indicates bearish sentiment.Change versus previous monthShort interest in BeyondSpring has recently decreased by 3.73%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBeyondSpring does not currently pay a dividend.Dividend GrowthBeyondSpring does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.89 News SentimentBeyondSpring has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for BeyondSpring this week, compared to 1 article on an average week.Search Interest1 people have searched for BYSI on MarketBeat in the last 30 days. Company Ownership1.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BeyondSpring insiders have not sold or bought any company stock.Percentage Held by Insiders29.31% of the stock of BeyondSpring is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions40.29% of the stock of BeyondSpring is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about BeyondSpring's insider trading history. Receive BYSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BYSI Stock News HeadlinesCritical Contrast: Intellia Therapeutics (NASDAQ:NTLA) & BeyondSpring (NASDAQ:BYSI)October 23, 2026 | americanbankingnews.comBeyondSpring Shareholders Ratify 2026 Auditor AppointmentOctober 13, 2026 | tipranks.comDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long. Tradewins plans to move the resource behind a paywall soon, closing off free access to the strategy breakdown. Readers who want a copy should grab it now, before the download link expires.October 27 at 1:00 AM | TradeWins (Ad)BeyondSpring Faces Nasdaq Listing Compliance RiskOctober 2, 2026 | tipranks.comBeyondSpring Inc. Announces FDA Fast Track Designation For Plinabulin And Docetaxel In Post-ICI Non-Squamous NSCLCSeptember 29, 2026 | marketscreener.comMBeyondSpring Inc. (BYSI) Discusses FDA Fast Track Designation and Strategic Transaction for Plinabulin in Post-ICI Non-Squamous NSCLC TranscriptSeptember 29, 2026 | seekingalpha.comBeyondSpring Gets FDA Fast Track For Plinabulin In Lung CancerSeptember 29, 2026 | rttnews.comBeyondSpring secures FDA fast track designation for Plinabulin as DUBLIN-4 phase 3 trial advancesSeptember 29, 2026 | msn.comSee More Headlines BYSI Stock Analysis - Frequently Asked Questions How have BYSI shares performed this year? BeyondSpring's stock was trading at $1.63 at the beginning of 2026. Since then, BYSI stock has decreased by 71.7% and is now trading at $0.4621. How were BeyondSpring's earnings last quarter? BeyondSpring Inc. (NASDAQ:BYSI) issued its earnings results on Friday, August, 14th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.54) by $0.52. When did BeyondSpring IPO? BeyondSpring (BYSI) raised $4 million in an IPO on Thursday, March 9th 2017. The company issued 174,286 shares at $20.00-$22.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) acted as the underwriter for the IPO. How do I buy shares of BeyondSpring? Shares of BYSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BeyondSpring own? Based on aggregate information from My MarketBeat watchlists, some other companies that BeyondSpring investors own include Tesla (TSLA), Alibaba Group (BABA), NIO (NIO), NVIDIA (NVDA), PayPal (PYPL), Palantir Technologies (PLTR) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/14/2026Today10/27/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 2 weeks, BYSI's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:BYSI CIK1677940 Webwww.beyondspringpharma.com Phone(646) 528-4184Fax1-646-882-4228Employees44Year Founded2010Profitability EPS (Trailing Twelve Months)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.01 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-28.88% Debt Debt-to-Equity RatioN/A Current Ratio0.70 Quick Ratio0.70 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.12 per share Price / Cash Flow3.79 Book Value($0.59) per share Price / Book-0.78Miscellaneous Outstanding Shares41,120,000Free Float29,068,000Market Cap$19.00 million OptionableOptionable Beta-0.21 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:BYSI) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our Partners6 Men Secretly Changed America’s Money. Now It’s Happening AgainIn 1910, six powerful men secretly met to lay the groundwork for the Federal Reserve, reshaping America's fina...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
